• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Serostim [somatropin (rDNA origin) for injection]

Audience: Pharmacists, distributors, and healthcare professionals

Serono, Inc. became aware of a counterfeit lot of Serostim [somatropin (rDNA origin) for injection]. The counterfeit material has been packaged to appear as drug product lot number S810-1A1. This is not a legitimate Serostim lot number. Preliminary information appears to indicate that the counterfeit material may have been distributed via the Internet. However, pharmacists should examine Serostim prior to dispensing to ensure that the package does not bear lot number S810-1A1.

[May 16, 2002 - Press Release - Serono]

Past MedWatch Alerts:

[May 17, 2001 - Letter - Serono, Inc.] PDF Format
[May 17, 2001 - Press Release - Serono, Inc.] PDF Format
[January 23, 2001 - Press Release - Serono, Inc.]